Welcome to our dedicated page for Arcadia Bioscien news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Bioscien stock.
Arcadia Biosciences, Inc. reports developments tied to its plant-based health and wellness products business, including Zola coconut water and agronomic wheat traits. Company news includes operating and financial results, business highlights, material agreements, shareholder voting matters, and capital-structure actions involving its publicly traded common stock.
Recurring updates also cover governance matters, security-structure disclosures, and other corporate events that affect the company's financing, reporting, and operating profile.
GoodWheat™ pasta, developed by Arcadia Biosciences (Nasdaq: RKDA), has launched as a healthier alternative in the pasta category, featuring one key ingredient. This innovative pasta boasts 4x the fiber (8g per serving) and 9g of protein, offering enhanced nutrition without compromising taste. Available in five varieties for $3.99 per 12-oz. package, GoodWheat pasta is Non-GMO Project Verified and kosher certified. The product aims to cater to consumers seeking healthier options while maintaining the traditional taste of pasta, marking a significant step for the company's expansion into better-for-you food products.
Arcadia Biosciences (RKDA) reported a remarkable 48% increase in sales from Q4 2021, reaching $3.2 million in Q1 2022, a 289% year-over-year growth. The company's transition to a consumer packaged goods (CPG) model and acquisitions of wellness brands contributed significantly to this growth. Moreover, Arcadia shipped its first retail orders of GoodWheat™ pasta and anticipates $2 million from the approval of HB4® soybeans in China. However, the company reported a net loss of $4.5 million, a shift from a profit of $2.1 million in Q1 2021.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) will release its Q1 2022 financial results on May 12, 2022, after market close. A conference call to discuss the results is scheduled for 4:30 p.m. Eastern time on the same day, with dial-in numbers provided. The company specializes in plant-based health products and has a range of offerings including GoodWheat™ and Zola® coconut water. A live webcast of the call will be available on Arcadia's investor website, with a recorded replay following the event.
Arcadia Biosciences (Nasdaq: RKDA) announced its fourth quarter and full-year 2021 financial results, revealing a significant revenue decline of 70% in Q4 2021 to $2.2 million, compared to $7.1 million in Q4 2020. Annual revenue also fell by 16% to $6.78 million. Operating expenses surged to $15.975 million in Q4 and $42.306 million for the year, leading to a net loss of $9.282 million for Q4 and $14.660 million for 2021. The company focuses on expanding its GoodWheat portfolio and recently appointed CPG industry veteran Stan Jacot as CEO to enhance growth strategies.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) announced it will release its 2021 fourth-quarter and full-year financial results after market close on March 30, 2022. A conference call is scheduled for 4:30 p.m. Eastern time to discuss the results and the company’s key strategic achievements over the year. Participants can join via U.S. Toll-Free Dial-In: +1-844-243-4690 or International Dial-In: +1-225-283-0138. A live webcast will be available on the company’s investor section, with a replay to follow.
Arcadia Biosciences (RKDA) has appointed Stan Jacot as the new CEO, effective February 2, 2022. Jacot brings a wealth of experience from his previous roles, including a successful tenure at Jane's Dough Foods, where he achieved significant growth. He aims to leverage Arcadia's innovative, plant-based product portfolio, highlighting the upcoming launch of GoodWheat pasta. The board's decision follows a nationwide search, and Jacot's appointment includes a stock option grant of 316,108 shares at an exercise price of $0.91, vesting over four years.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) appointed Kevin Comcowich as interim CEO effective January 1, 2022, while the board finalizes its search for a permanent replacement. Comcowich, the current Chairman since 2017, takes over following the departure of Matthew Plavan, the CEO since 2019, on December 31, 2021. The company is expanding into the consumer packaged goods sector, emphasizing plant-based health products.
Arcadia Biosciences (Nasdaq: RKDA) has appointed Brian Schaffer as Senior Vice President of Sales to spearhead the retail launch of its GoodWheat brand in 2022. Schaffer brings extensive experience from top CPG firms like PepsiCo and Kellogg's, enhancing the company's strategy in a competitive market. His predecessor, Chris Cuvelier, will leave the company on November 30 to pursue other opportunities. This leadership change aims to bolster growth in Arcadia's plant-based health products, including Zola coconut water and Saavy Naturals.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) reported significant growth in Q3 2021 with revenues soaring to $2.4 million, a 657% increase from $314,000 in Q3 2020. The nine-month revenue grew to $4.6 million, a 410% rise from the previous year. This growth was attributed to the newly acquired wellness brands and increased sales of GoodHemp and GoodWheat products. However, total operating expenses also rose to $11.1 million, leading to a net loss of $2.2 million, down from $6.4 million a year earlier. The company is set for a full launch of its GoodWheat pasta line in Q1 2022.
Arcadia Biosciences (Nasdaq: RKDA) will disclose its Q3 financial results and business highlights on November 15, 2021. The announcement follows their strategy to enhance plant-based health products. A conference call is scheduled for 4:30 p.m. Eastern time to review the outcomes and significant achievements. Investors can join via U.S. Toll-Free or International Dial-In numbers. A live webcast will also be available on their investor website, along with a replay post-call.